Brege Laura

Director at MIRM; Director at ACAD; Director at PCRX, and 1 more

Sold, on record
$17.6M
Dollars the filings state
Form 4 sales
39
Latest Sep 11, 2025
Form 144 notices
3
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 144 notice PCRXNotice
    Apr 3 2023

    Filed to sell 7,000 shares ($285k)

    Brege Laura, Director

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale PCRXRoutine
    Apr 3 same day

    Sold 7,000 shares at $40.72 ($285k)

    Brege Laura, Director

    10b5-1 planSold 40.8% of holdings ($698k position)10,147 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 144 notice PCRXNotice
    Jun 5 +63 days

    Filed to sell 600 shares ($23k)

    Brege Laura, Director

    10b5-1 planFiling

  4. 4 Form 4 sale PCRXRoutine
    Jun 5 same day

    Sold 600 shares at $38.74 ($23k)

    Brege Laura, Director

    10b5-1 planSold 5.9% of holdings ($393k position)9,547 shares leftFollows a Form 144Filing

  5. 5 Form 144 notice ACADNotice
    Jun 12 +7 days

    Filed to sell 4,500 shares ($112k)

    Brege Laura, Director

    10b5-1 planFiling

  6. 6 Form 4 sale ACADRoutine
    Jun 12 same day

    Sold 4,500 shares at $24.87 ($112k)

    Brege Laura, Director

    10b5-1 planSold 25% of holdings ($448k position)13,502 shares leftFollows a Form 144Filing

  7. 7 Form 4 sale ACADUnusual
    Jun 4 +723 days

    Sold 14,446 shares at $21.78 ($315k)

    Brege Laura, Director

    No 10b5-1 planSold 48.9% of holdings ($643k position)15,095 shares leftFiling

  8. 8 Form 4 sale MIRMUnusual
    Sep 11 +99 days

    Sold 17,000 shares at $74.40 ($1.3M)

    Brege Laura, Director

    No 10b5-1 planSold 52% of holdings ($2.4M position)15,703 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (42)

Form 144 notices and Form 4 sales by Brege Laura
Source
Sep 11, 2025MIRMDirectorForm 4 sale17,000$1.3M52.0%UnusualSEC
Jun 4, 2025ACADDirectorForm 4 sale14,446$315k48.9%UnusualSEC
Jun 12, 2023ACADDirectorForm 4 sale4,500$112k25.0%RoutineSEC
Jun 12, 2023ACADDirectorForm 144 notice4,500$112kNoticeSEC
Jun 5, 2023PCRXDirectorForm 4 sale600$23k5.9%RoutineSEC
Jun 5, 2023PCRXDirectorForm 144 notice600$23kNoticeSEC
Apr 3, 2023PCRXDirectorForm 4 sale7,000$285k40.8%RoutineSEC
Apr 3, 2023PCRXDirectorForm 144 notice7,000$285kNoticeSEC
Jan 12, 2023ACADDirectorForm 4 sale12,500$228k100.0%UnusualSEC
Nov 16, 2020PCRXDirectorForm 4 sale12,000$791k60.2%UnusualSEC
Jun 5, 2020PCRXDirectorForm 4 sale2,100$102k24.0%Plan not statedSEC
Jan 7, 2020ACADDirectorForm 4 sale10,000$422k100.0%UnusualSEC
Jan 9, 2019ACADDirectorForm 4 sale10,000$200k100.0%UnusualSEC
Jan 2, 2018ACADDirectorForm 4 sale25,000$752k100.0%UnusualSEC
Jun 6, 2016PCRXDirectorForm 4 sale1,000$47k50.0%UnusualSEC
Feb 11, 2015ACADDirectorForm 4 sale10,000$336k100.0%UnusualSEC
Sep 15, 2014ACADDirectorForm 4 sale10,000$281k100.0%UnusualSEC
May 9, 2014PCRXDirectorForm 4 sale10,000$738k100.0%UnusualSEC
Apr 4, 2014ACADDirectorForm 4 sale14,285$322k100.0%UnusualSEC
Jan 15, 2014ACADDirectorForm 4 sale10,000$242k100.0%UnusualSEC
Dec 10, 2013ACADDirectorForm 4 sale44,117$1M100.0%UnusualSEC
Oct 10, 2013ACADDirectorForm 4 sale10,000$216k100.0%UnusualSEC
Sep 10, 2013ACADDirectorForm 4 sale46,153$1.1M100.0%UnusualSEC
Oct 14, 2011ONYX PHARMACEUTICALS INCEVP, Corporate AffairsForm 4 sale10,000$360k20.1%Plan not statedSEC
Jul 14, 2011ONYX PHARMACEUTICALS INCEVP, Corporate AffairsForm 4 sale10,000$350k20.2%Plan not statedSEC
Apr 26, 2011ONYX PHARMACEUTICALS INCEVP, Corporate AffairsForm 4 sale10,000$350k20.2%Plan not statedSEC
Apr 1, 2011ONYX PHARMACEUTICALS INCEVP, Corporate AffairsForm 4 sale7,000$245k15.1%Plan not statedSEC
Jan 18, 2011ONYX PHARMACEUTICALS INCEVP & Chief Operating OfficerForm 4 sale12,500$446k39.8%UnusualSEC
Nov 8, 2010ONYX PHARMACEUTICALS INCEVP & Chief Operating OfficerForm 4 sale25,000$750k57.5%UnusualSEC
Apr 15, 2010ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$380k40.8%UnusualSEC
Apr 1, 2010ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale7,667$231k29.7%UnusualSEC
Jan 15, 2010ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$377k41.3%UnusualSEC
Dec 2, 2009ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$375k41.6%UnusualSEC
Jul 22, 2009ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale25,000$898k58.8%UnusualSEC
Apr 1, 2009ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale5,333$149k23.6%Plan not statedSEC
Jan 15, 2009ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$410k44.5%UnusualSEC
Nov 7, 2008ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$375k44.8%UnusualSEC
Jul 15, 2008ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$469k44.8%UnusualSEC
Apr 15, 2008ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$415k45.3%UnusualSEC
Apr 2, 2008ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale2,142$66k12.4%Plan not statedSEC
Jan 15, 2008ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale12,500$636k50.2%UnusualSEC
Aug 10, 2007ONYX PHARMACEUTICALS INCEVP and Chief Business OfficerForm 4 sale50,000$1.6M81.3%UnusualSEC